Structure in partnering talks for oral GLP-1 as mid-stage readout nears

It is a truth universally acknowledged that a biotech in possession of a mid-stage GLP-1 must be in want of a partner. Structure Therapeutics is no exception. With Phase 2 trials of its obesity pill ...